294 related articles for article (PubMed ID: 30552782)
1. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice.
Wang YS; Du L; Liang X; Meng P; Bi L; Wang YL; Wang C; Tang B
Hepatology; 2019 Apr; 69(4):1614-1631. PubMed ID: 30552782
[TBL] [Abstract][Full Text] [Related]
2. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.
Martínez-López N; García-Rodríguez JL; Varela-Rey M; Gutiérrez V; Fernández-Ramos D; Beraza N; Aransay AM; Schlangen K; Lozano JJ; Aspichueta P; Luka Z; Wagner C; Evert M; Calvisi DF; Lu SC; Mato JM; Martínez-Chantar ML
Gastroenterology; 2012 Sep; 143(3):787-798.e13. PubMed ID: 22687285
[TBL] [Abstract][Full Text] [Related]
3. Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria.
Shaw E; Talwadekar M; Rashida Z; Mohan N; Acharya A; Khatri S; Laxman S; Kolthur-Seetharam U
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31685549
[TBL] [Abstract][Full Text] [Related]
4. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
[TBL] [Abstract][Full Text] [Related]
5. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
[TBL] [Abstract][Full Text] [Related]
6. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.
Csibi A; Fendt SM; Li C; Poulogiannis G; Choo AY; Chapski DJ; Jeong SM; Dempsey JM; Parkhitko A; Morrison T; Henske EP; Haigis MC; Cantley LC; Stephanopoulos G; Yu J; Blenis J
Cell; 2013 May; 153(4):840-54. PubMed ID: 23663782
[TBL] [Abstract][Full Text] [Related]
7. A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest.
Majd S; Power JHT; Chataway TK; Grantham HJM
BMC Cell Biol; 2018 Jun; 19(1):7. PubMed ID: 29921218
[TBL] [Abstract][Full Text] [Related]
8. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z
Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843
[TBL] [Abstract][Full Text] [Related]
9. SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK.
Ho L; Titus AS; Banerjee KK; George S; Lin W; Deota S; Saha AK; Nakamura K; Gut P; Verdin E; Kolthur-Seetharam U
Aging (Albany NY); 2013 Nov; 5(11):835-49. PubMed ID: 24296486
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway.
Li J; Zhan H; Ren Y; Feng M; Wang Q; Jiao Q; Wang Y; Liu X; Zhang S; Du L; Wang Y; Wang C
Cell Death Differ; 2023 Feb; 30(2):313-326. PubMed ID: 36209169
[TBL] [Abstract][Full Text] [Related]
11. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
13. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.
Cai G; Ge Z; Xu Y; Cai L; Sun P; Huang G
Sci Rep; 2022 Jul; 12(1):12208. PubMed ID: 35842463
[TBL] [Abstract][Full Text] [Related]
14. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.
Jeong SM; Xiao C; Finley LW; Lahusen T; Souza AL; Pierce K; Li YH; Wang X; Laurent G; German NJ; Xu X; Li C; Wang RH; Lee J; Csibi A; Cerione R; Blenis J; Clish CB; Kimmelman A; Deng CX; Haigis MC
Cancer Cell; 2013 Apr; 23(4):450-63. PubMed ID: 23562301
[TBL] [Abstract][Full Text] [Related]
15. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
16. mTOR remains unchanged in diet-resistant (DR) rats despite impaired LKB1/AMPK cascade in adipose tissue.
Han J; Liang H; Tian D; Du J; Wang Q; Xi P; Wang H; Li Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):333-339. PubMed ID: 27235551
[TBL] [Abstract][Full Text] [Related]
17. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
18. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
19. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling.
Fang G; Zhang P; Liu J; Zhang X; Zhu X; Li R; Wang H
Cancer Lett; 2019 Oct; 463():11-26. PubMed ID: 31404613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]